Literature DB >> 15371334

Signaling to NF-kappaB.

Matthew S Hayden1, Sankar Ghosh.   

Abstract

The transcription factor NF-kappaB has been the focus of intense investigation for nearly two decades. Over this period, considerable progress has been made in determining the function and regulation of NF-kappaB, although there are nuances in this important signaling pathway that still remain to be understood. The challenge now is to reconcile the regulatory complexity in this pathway with the complexity of responses in which NF-kappaB family members play important roles. In this review, we provide an overview of established NF-kappaB signaling pathways with focus on the current state of research into the mechanisms that regulate IKK activation and NF-kappaB transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371334     DOI: 10.1101/gad.1228704

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  1444 in total

1.  Estrogen suppresses heptatic IκB expression during short-term alcohol exposure.

Authors:  Eric G Lee; Bethany M Mickle-Kawar; Lester A Reinke; Randle M Gallucci
Journal:  Inflamm Res       Date:  2012-06-06       Impact factor: 4.575

Review 2.  Selectivity of the NF-{kappa}B response.

Authors:  Ranjan Sen; Stephen T Smale
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-14       Impact factor: 10.005

3.  Fluoxetine protects neurons against microglial activation-mediated neurotoxicity.

Authors:  Feng Zhang; Hui Zhou; Belinda C Wilson; Jing-Shan Shi; Jau-Shyong Hong; Hui-Ming Gao
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

4.  IKKβ-induced inflammation impacts the kinetics but not the magnitude of the immune response to a viral vector.

Authors:  Emily L Hopewell; Crystina C Bronk; Michael Massengill; Robert W Engelman; Amer A Beg
Journal:  Eur J Immunol       Date:  2012-01-13       Impact factor: 5.532

5.  Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-kappaB and crosstalk between the extrinsic and intrinsic apoptotic pathways.

Authors:  Chiung-Hua Huang; Jih-Hwa Guh; Grace Shiahuy Chen; Pin-Hsuan Lu; Ji-Wang Chern
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-08       Impact factor: 3.000

6.  Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.

Authors:  Emanuel Wyler; Monika Kaminska; Yves-Marie Coïc; Françoise Baleux; Michel Véron; Fabrice Agou
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

7.  Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma.

Authors:  Jeff Johnson; Zonggao Shi; Yueying Liu; M Sharon Stack
Journal:  Oral Oncol       Date:  2014-02-28       Impact factor: 5.337

8.  MiR-663a/MiR-423-5p are involved in the pathogenesis of lupus nephritis via modulating the activation of NF-κB by targeting TNIP2.

Authors:  Weisong Wang; Junjie Gao; Fangli Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

9.  Interleukin-27 enhances TNF-α-mediated activation of human coronary artery endothelial cells.

Authors:  Huai-Na Qiu; Bin Liu; Weihua Liu; Shiming Liu
Journal:  Mol Cell Biochem       Date:  2015-09-19       Impact factor: 3.396

10.  NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation.

Authors:  Mikyoung Chang; Andrew J Lee; Leo Fitzpatrick; Minying Zhang; Shao-Cong Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.